Big pharma, women, and the labour of love

Description

Moves beyond the search for a sexual pharmaceutical drug for women to ask a broader question: how does the medicalization of female sexuality already affect women's lives? Using in-depth interviews with doctors, patients, therapists, and other medical practitioners, Cacchioni shows that, whatever the future of Flibanserin (a drug proposed to treat low sexual desire in women, dubbed the "pink Viagra"), heterosexual women often now feel expected to take on the job of managing their and their partners' sexual desires. Her investigation opens up a wide-ranging discussion about the true impact of sexuality's medicalization. --From publisher description.;Preface : testifying at the US Food and Drug Administration -- Introduction : the labour of love in the sexual pharmaceutical era -- The rise and decline of big pharma's "sexual revolution" -- Treating women's sexual pain : biomedicalized, demedicalized, and do-it-yourself approaches -- The limits of normative heterosex -- Sex work : a labour of love -- Refusing heteronormative sex work -- A woman's work is never done -- Epilogue : the sexual pharmaceutical industry and its discontents. Preface : testifying at the US Food and Drug Administration -- Introduction : the labour of love in the sexual pharmaceutical era -- The rise and decline of big pharma's "sexual revolution" -- Treating women's sexual pain : biomedicalized, demedicalized, and do-it-yourself approaches -- The limits of normative heterosex -- Sex work : a labour of love -- Refusing heteronormative sex work -- A woman's work is never done -- Epilogue : the sexual pharmaceutical industry and its discontents.